1Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin,2005,55:10-30. 被引量：1
2Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol,1983,15:10-17. 被引量：1
3Thigpen JT, Brady MF, Alvarez RD, et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol,1999,17:1736-1744. 被引量：1
4Niwa K, Tagami K, Lian Z, et al. Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG,2005,112:317-320. 被引量：1
5Vishnevsky AS, Bokhman YaV, Loutfi G. Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients. Eur J Gynaecol Oncol,1993,14:150-153. 被引量：1
6Kaku T, Yoshikawa H, Tsuda H, et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett,2001,167:39-48. 被引量：1
7Lowe MP, Cooper BC, Sood AK, et al. Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypis. Gynecol Oncol,2003,91:569-572. 被引量：1
8Von Minckwitz G, Loibl S, Brunnert K, et al. Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial. Eur J Cancer,2002,38:2265-2271. 被引量：1
9Martin-Hirsch PL, Jarvis G, Kitchener H, et al. Progestagens for endometrial cancer. Cochrane Database Syst Rev,2000,CD001040. 被引量：1
10Nola M, Jukic S, Ilic-Forko J, et al. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Gynecol Oncol,1999,72:331-336. 被引量：1
5Lubusky M, Dzvincuk P. Preoperative assessment of myometrial invasion in endometrial cancer patients by ultrasonography and magnetic resonance imaging (MRI)[J]. Ceska Gynekol, 2006, 71 (5) : 394. 被引量：1
6Ivanov S. Early diagnosis of endometrial preeancer and cancer by combined use of progesterone test and transvaginal uhrasonography in high risk groups of patients with diabetes, blood hypertension, and obesity [J]. Akush Ginekol (Sofiia), 2006, 45 (5) : 54. 被引量：1
7Chung HH, Kim JW. Use of preoperative serum CA - 125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer [J] . Acta Obstet Gynecol Scand, 2006, 85 (12) : 1501. 被引量：1
8Viale G, Regan MM. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopansal women with early breast cancer: results from the BIG 1 -98 collaborative groups [J] . J Clin Oncol, 2007, 25 (25): 3846. 被引量：1
9Singh M, Zaino RJ. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group study[J]. Gynecol Oncol, 2007, 106 (2) : 325. 被引量：1
10Shabani N, Mylonas I. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium [J]. Anticancer Res, 2007, 27 (4A) : 2027. 被引量：1
